Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis C
Φόρτωση...
Ημερομηνία
Συγγραφείς
Economou, M.
Milionis, H.
Filis, S.
Baltayiannis, G.
Christou, L.
Elisaf, M. S.
Tsianos, E.
Τίτλος Εφημερίδας
Περιοδικό ISSN
Τίτλος τόμου
Εκδότης
Περίληψη
Τύπος
Είδος δημοσίευσης σε συνέδριο
Είδος περιοδικού
peer-reviewed
Είδος εκπαιδευτικού υλικού
Όνομα συνεδρίου
Όνομα περιοδικού
J Gastroenterol Hepatol
Όνομα βιβλίου
Σειρά βιβλίου
Έκδοση βιβλίου
Συμπληρωματικός/δευτερεύων τίτλος
Περιγραφή
BACKGROUND: Hepatitis C virus (HCV) partially interacts with low-density lipoprotein (LDL) receptors, suggesting a role for lipids in regulating HCV clearance. Our aim was to study if baseline lipids can discriminate responders from non-responders among patients with HCV infection. METHODS: A total of 109 HCV patients were studied. Laboratory measurements included serum lipids, aminotransferases and viral load, as well as HCV genotype determinations. RESULTS: Responders (n = 53) had significantly higher serum baseline levels of total cholesterol, LDL cholesterol and apolipoprotein B compared to non-responders (n = 56). Multivariate logistic regression analysis showed that a 10 mg/dL increase in total cholesterol was associated with 3.02 higher odds of responding to treatment (95% CI 1.74-5.32, P < 0.001), while a 10 mg/dL increase in apolipoprotein B levels was associated with 1.81 higher odds of responding to treatment (95% CI 1.37-2.54, P < 0.001), after adjustment for age, sex, body mass index (BMI), smoking habits, baseline viral load, liver histology and administration of pegylated interferon. An inverse association between BMI and response to treatment was also evident (adjusted odds ratio 0.73, 95% CI 0.55-0.96; P = 0.03). CONCLUSION: Baseline serum total cholesterol levels and BMI could be helpful in discriminating responders to antiviral therapy among patients with HCV infection.
Περιγραφή
Λέξεις-κλειδιά
Antiviral Agents/*therapeutic use, Apolipoproteins B/*blood, Cholesterol/*blood, Cholesterol, LDL/*blood, Female, Hepatitis C, Chronic/*blood/*drug therapy, Humans, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies
Θεματική κατηγορία
Παραπομπή
Σύνδεσμος
http://www.ncbi.nlm.nih.gov/pubmed/17498221
http://onlinelibrary.wiley.com/store/10.1111/j.1440-1746.2007.04911.x/asset/j.1440-1746.2007.04911.x.pdf?v=1&t=h0p11ldo&s=1763ab797979252a5963b724c5973b85ef31f9b6
http://onlinelibrary.wiley.com/store/10.1111/j.1440-1746.2007.04911.x/asset/j.1440-1746.2007.04911.x.pdf?v=1&t=h0p11ldo&s=1763ab797979252a5963b724c5973b85ef31f9b6
Γλώσσα
en
Εκδίδον τμήμα/τομέας
Όνομα επιβλέποντος
Εξεταστική επιτροπή
Γενική Περιγραφή / Σχόλια
Ίδρυμα και Σχολή/Τμήμα του υποβάλλοντος
Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής